SCHEMBL6981471

SCHEMBL6981471

COc1cc2c(=O)c(Cc3cccnc3)cn3c4ccc(Cl)cc4c(c1)c23

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA5 P31644 4/20 0.43
GABRA1 P14867 3/20 0.43
MAT2A P31153 1/20 0.40
EGFR P00533 1/20 0.39
PTGS2 P35354 2/20 0.36
ALDH1A1 P00352 3/20 0.35
CNR1 P21554 1/20 0.35
CNR2 P34972 1/20 0.35
MAPT P10636 1/20 0.35
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
ACHE P22303 1/20 0.35
PLA2G7 Q13093 2/20 0.35
PKM P14618 2/20 0.35
OPRM1 P35372 1/20 0.35
OPRD1 P41143 1/20 0.35
KMT2A Q03164 1/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6981678 0.92 GABRA1 (0.46) GABRA5GABRA1ALDH1A1CNR1CNR2
SCHEMBL6979943 0.89 GABRA1 (0.39) GABRA5GABRA1ALDH1A1CNR1CNR2
SCHEMBL6982921 0.89 PTGDR2 (0.43) GABRA5GABRA1ALDH1A1CNR1CNR2
SCHEMBL6977175 0.89 GABRA1 (0.39) GABRA5GABRA1ALDH1A1CNR1CNR2
SCHEMBL6979014 0.88 GABRA1 (0.41) GABRA5GABRA1ALDH1A1CNR1CNR2
SCHEMBL8159124 0.87 GABRA5 (0.41) GABRA5GABRA1MAT2AEGFRALDH1A1
SCHEMBL6975201 0.87 GABRA1 (0.43) GABRA5GABRA1ALDH1A1MAPTLMNA
SCHEMBL7670695 0.86 GABRA5 (0.43) GABRA5GABRA1MAT2AEGFRALDH1A1
SCHEMBL8156884 0.85 TSHR (0.41) GABRA5GABRA1EGFRALDH1A1MAPT
SCHEMBL6973875 0.84 GABRA1 (0.42) GABRA5GABRA1ALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0985671-B1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARM CO LTD (JP) 2003-04-02 EP disclosed
US-6197768-B1 THERAPY, PREVENTION ISCHEMIC HEART DISEASE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2001-03-06 US disclosed
EP-0992240-A1 THERAPEUTIC AGENT FOR ERECTION FAILURE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-04-12 EP disclosed
EP-0985671-A1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-03-15 EP disclosed
US-6018046-A SELECTIVE ACTION IN INHIBITING CYCLIC GMP-PHOSPHODIESTERASE (CGMP-PDE); PHARMACEUTICALS FOR TREATING DISEASES AGAINST WHICH THE INHIBITORY ACTION IS EFFECTIVE, SUCH AS PULMONARY HYPERTENSION MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-01-25 US disclosed